-
Something wrong with this record ?
Ochratoxin A: developmental and reproductive toxicity-an overview
F. Malir, V. Ostry, A. Pfohl-Leszkowicz, E. Novotna,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
24395216
DOI
10.1002/bdrb.21091
Knihovny.cz E-resources
- MeSH
- Calcium Channel Blockers toxicity MeSH
- Endocrine Disruptors toxicity MeSH
- Carcinogens toxicity MeSH
- Cricetinae MeSH
- Rats MeSH
- Humans MeSH
- Mice MeSH
- Ochratoxins toxicity MeSH
- Reproduction drug effects MeSH
- Spermatozoa abnormalities MeSH
- Pregnancy MeSH
- Teratogenesis drug effects MeSH
- Teratogens toxicity MeSH
- Testicular Neoplasms chemically induced MeSH
- Environmental Exposure adverse effects MeSH
- Animals MeSH
- Check Tag
- Cricetinae MeSH
- Rats MeSH
- Humans MeSH
- Male MeSH
- Mice MeSH
- Pregnancy MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Ochratoxin A (OTA) is nephrotoxic, hepatotoxic, reprotoxic, embryotoxic, teratogenic, neurotoxic, immunotoxic, and carcinogenic for laboratory and farm animals. Male and female reproductive health has deteriorated in many countries during the last few decades. A number of toxins in environment are suspected to affect reproductive system in male and female. OTA is one of them. OTA has been found to be teratogenic in several animal models including rat, mouse, hamster, quail, and chick, with reduced birth weight and craniofacial abnormalities being the most common signs. The presence of OTA also results in congenital defects in the fetus. Neither the potential of OTA to cause malformations in human nor its teratogenic mode of action is known. Exposure to OTA leads to increased embryo lethality manifested as resorptions or dead fetuses. The mechanism of OTA transfer across human placenta (e.g., which transporters are involved in the transfer mechanism) is not fully understood. Some of the toxic effects of OTA are potentiated by other mycotoxins or other contaminants. Therefore, OTA exposure of pregnant women should be minimized. OTA has been shown to be an endocrine disruptor and a reproductive toxicant, with abilities of altering sperm quality. Other studies have shown that OTA is a testicular toxin in animals. Thus, OTA is a biologically plausible cause of testicular cancer in man.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008415
- 003
- CZ-PrNML
- 005
- 20150408095903.0
- 007
- ta
- 008
- 150306s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/bdrb.21091 $2 doi
- 035 __
- $a (PubMed)24395216
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Malir, Frantisek $u Department of Biology, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic.
- 245 10
- $a Ochratoxin A: developmental and reproductive toxicity-an overview / $c F. Malir, V. Ostry, A. Pfohl-Leszkowicz, E. Novotna,
- 520 9_
- $a Ochratoxin A (OTA) is nephrotoxic, hepatotoxic, reprotoxic, embryotoxic, teratogenic, neurotoxic, immunotoxic, and carcinogenic for laboratory and farm animals. Male and female reproductive health has deteriorated in many countries during the last few decades. A number of toxins in environment are suspected to affect reproductive system in male and female. OTA is one of them. OTA has been found to be teratogenic in several animal models including rat, mouse, hamster, quail, and chick, with reduced birth weight and craniofacial abnormalities being the most common signs. The presence of OTA also results in congenital defects in the fetus. Neither the potential of OTA to cause malformations in human nor its teratogenic mode of action is known. Exposure to OTA leads to increased embryo lethality manifested as resorptions or dead fetuses. The mechanism of OTA transfer across human placenta (e.g., which transporters are involved in the transfer mechanism) is not fully understood. Some of the toxic effects of OTA are potentiated by other mycotoxins or other contaminants. Therefore, OTA exposure of pregnant women should be minimized. OTA has been shown to be an endocrine disruptor and a reproductive toxicant, with abilities of altering sperm quality. Other studies have shown that OTA is a testicular toxin in animals. Thus, OTA is a biologically plausible cause of testicular cancer in man.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a blokátory kalciových kanálů $x toxicita $7 D002121
- 650 _2
- $a karcinogeny $x toxicita $7 D002273
- 650 _2
- $a křečci praví $7 D006224
- 650 _2
- $a endokrinní disruptory $x toxicita $7 D052244
- 650 _2
- $a vystavení vlivu životního prostředí $x škodlivé účinky $7 D004781
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a ochratoxiny $x toxicita $7 D009793
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a rozmnožování $x účinky léků $7 D012098
- 650 _2
- $a spermie $x abnormality $7 D013094
- 650 _2
- $a teratogeneze $x účinky léků $7 D064793
- 650 _2
- $a teratogeny $x toxicita $7 D013723
- 650 _2
- $a testikulární nádory $x chemicky indukované $7 D013736
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Ostry, Vladimir
- 700 1_
- $a Pfohl-Leszkowicz, Annie
- 700 1_
- $a Novotna, Eva
- 773 0_
- $w MED00007311 $t Birth defects research. Part B, Developmental and reproductive toxicology. Clinical and molecular teratology $x 1542-9741 $g Roč. 98, č. 6 (2013), s. 493-502
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24395216 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20150408100139 $b ABA008
- 999 __
- $a ok $b bmc $g 1065688 $s 891215
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 98 $c 6 $d 493-502 $i 1542-9741 $m Birth defects research. Part B. Developmental and reproductive toxicology $n Birth Defects Res Part B Dev Reprod Toxicol $x MED00007311 $o Clinical and molecular teratology
- LZP __
- $a Pubmed-20150306